Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07124195) titled 'Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting' on Aug. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: The First Affiliated Hospital of Xinxiang Medical College

Condition: Malignant Solid Tumors Moderate to High Emetogenic Chemotherapy (MEC/HEC) Drugs

Intervention: Drug: Medroxyprogesterone acetate oral suspension Combination Product: high antiemetic regimen

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: August ...